1620 Investment Advisors »

X4 Pharmaceuticals shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 10k 1.39
2023-09-30 $11k 10k 1.09
2023-06-30 $19k 10k 1.94

More positions owned by 1620 Investment Advisors

Spdr Ser Tr Portfolio Intrmd (SPIB)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Spdr Index Shs Fds Msci Eafe Strtgc (QEFA)
Tri-Continental Corporation (TY)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
Ishares Tr Shrt Nat Mun Etf (SUB)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
TJX Companies (TJX)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Ea Series Trust Freedom 100 Em (FRDM)
Eaton Corp SHS (ETN)
Apple (AAPL)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)

View all positions for 1620 Investment Advisors

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
NEA Management Company
BlackRock
Vanguard Group
OrbiMed Advisors
Soleus Capital Management
Adage Capital Partners GP
Sio Capital Management
Perceptive Advisors
Kingdon Capital Management
Axa
Geode Capital Management
Ensign Peak Advisors
Avidity Partners Management
Morgan Stanley

View all funds holding X4 Pharmaceuticals